180 related articles for article (PubMed ID: 21084001)
1. Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unit.
Sandgren P; Saeed K
Blood Transfus; 2011 Apr; 9(2):182-8. PubMed ID: 21084001
[TBL] [Abstract][Full Text] [Related]
2. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
3. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
4. The effects of pneumatic tube transport on fresh and stored platelets in additive solution.
Sandgren P; Larsson S; Wai-San P; Aspevall-Diedrich B
Blood Transfus; 2014 Jan; 12(1):85-90. PubMed ID: 24333086
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method.
Sandgren P; Tolksdorf F; Struff WG; Gulliksson H
Vox Sang; 2011 Jul; 101(1):35-43. PubMed ID: 21175668
[TBL] [Abstract][Full Text] [Related]
6. Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.
Ohlsson S; Diedrich B; Uhlin M; Sandgren P
Vox Sang; 2018 Oct; 113(7):611-621. PubMed ID: 30156292
[TBL] [Abstract][Full Text] [Related]
7. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium.
Gulliksson H; AuBuchon JP; Cardigan R; van der Meer PF; Murphy S; Prowse C; Richter E; Ringwald J; Smacchia C; Slichter S; de Wildt-Eggen J
Vox Sang; 2003 Oct; 85(3):199-205. PubMed ID: 14516450
[TBL] [Abstract][Full Text] [Related]
8. The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.
Reikvam H; Marschner S; Apelseth TO; Goodrich R; Hervig T
Blood Transfus; 2010 Jul; 8(3):186-92. PubMed ID: 20671879
[TBL] [Abstract][Full Text] [Related]
9. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.
Plaza EM; Lozano ML; Guiu IS; Egea JM; Vicente V; De Terán LC; Rivera J
Blood Transfus; 2012 Oct; 10(4):480-9. PubMed ID: 22682335
[TBL] [Abstract][Full Text] [Related]
11. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
Sandgren P; Callaert M; Shanwell A; Gulliksson H
Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
[TBL] [Abstract][Full Text] [Related]
12. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
[TBL] [Abstract][Full Text] [Related]
13. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
14. In vitro storage characteristics of platelet concentrates suspended in 70% SSP+(TM) additive solution versus plasma over a 14-day storage period.
Saunders C; Rowe G; Wilkins K; Holme S; Collins P
Vox Sang; 2011 Aug; 101(2):112-21. PubMed ID: 21414010
[TBL] [Abstract][Full Text] [Related]
15. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
16. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
[TBL] [Abstract][Full Text] [Related]
17. Extended storage of platelets in SSP platelet additive solution.
Hornsey VS; McColl K; Drummond O; McMillan L; Morrison A; Morrison L; MacGregor IR; Prowse CV
Vox Sang; 2006 Jul; 91(1):41-6. PubMed ID: 16756600
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
19. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium.
Gulliksson H; AuBuchon JP; Vesterinen M; Sandgren P; Larsson S; Pickard CA; Herschel I; Roger J; Tracy JE; Langweiler M;
Vox Sang; 2002 Apr; 82(3):131-6. PubMed ID: 11952987
[TBL] [Abstract][Full Text] [Related]
20. In vitro analysis of volume-reduced washed platelet concentrates stored in bicarbonated Ringer's solution containing less than 5% residual plasma.
Oikawa S; Minegishi M; Endo K; Kawashima W; Suzuki K; Shimizu H
Vox Sang; 2016 Jul; 111(1):16-21. PubMed ID: 26918327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
